Sirion, Acucela sign deal for gene therapy development – Healio
|
Sirion, Acucela sign deal for gene therapy development
Healio Through the agreement, which Acucela is using to bolster its entrance into the gene therapy market to find a genetic treatment for retinitis pigmentosa, milestone payments will be made to Sirion and additional royalties will be paid on sales from … |
